Meituan
SWB:9MD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Meituan
SWB:9MD
|
CN |
|
B
|
Boundless Bio Inc
NASDAQ:BOLD
|
US |
|
S
|
Suncor Energy Inc
DUS:SM3
|
CA |
|
ADTRAN Holdings Inc
F:QH9
|
US |
|
Elicera Therapeutics AB
F:8E8
|
SE |
Wall St Price Targets
9MD Price Targets Summary
Meituan
According to Wall Street analysts, the average 1-year price target for 9MD is 12.87 EUR with a low forecast of 6.15 EUR and a high forecast of 33.42 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9MD's stock price target?
Price Target
12.87
EUR
According to Wall Street analysts, the average 1-year price target for 9MD is 12.87 EUR with a low forecast of 6.15 EUR and a high forecast of 33.42 EUR.
What is the Revenue forecast for Meituan?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Meituan?
Projected CAGR
19%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 38%. The projected CAGR for the next 3 years is 19%.
